Each capsule contains Co-enzyme Q10 25 mg and 50 mg, respectively.
Alerten also contains fractionated coconut oil as an inactive ingredient.
Co-enzyme Q10 is a vitamin-like substance which is synthesized in the body and can be found in some food. The mitochondrias are the energy generators of the cells and the highest proportion of Q10 is in the cells that do the most work, notably the myocardium and the liver.
In congestive heart failure, the heart muscles become weak resulting in poor circulation and shortness of breath. Patients with CHF have significantly lower levels of CoQ10 in heart muscle cells than healthy people.
25-mg: Supportive treatment for patients with congestive heart failure. 50-mg: Adjunctive therapy to standard treatment of periodontal disease and prevention of Co-enzyme Q10 depletion in patients taking HMG-CoA reductase inhibitor.
25-mg: 1 emulcap daily after a meal as a dietary supplement. 50-mg: 1-2 emulcap 2-3 times daily with meals.
Young children, pregnant or lactating women or those with severe liver or kidney diseases.
There is 1 report of Co-enzyme Q10 decreasing the effectiveness of warfarin. Those taking warfarin should be aware of this possibility.
Occasional reports of mild gastrointestinal symptoms eg, nausea, diarrhea and epigastric distress in particularly with higher doses (≥200 mg daily).
Do not use Alerten if there are any significant changes in appearance of the capsules.
Store below 25°C in a dry place. Protect from light.
Shelf-Life: 50 mg: 2 years.
C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.
Emulcap (softgel) 25 mg x 3 x 10's. 50 mg x 3 x 10's.